The Ministry of Health and Welfare (MoHW) and the Global Training Hub for Biomanufacturing Support Foundation (GTHB-SF),...
Ascend Advanced Therapies (Ascend), a gene to GMP development partner, has confirmed multi-million-dollar investme...
Industries with international operations face increasing vulnerability to supply chain disruptions. This risk is particu...
ST Pharm, a leading technology-driven RNA CDMO based in South Korea, and Belgium-based Quantoom Biosciences, a specialis...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...
Novo Nordisk Indonesia and Bio Farma have announced the signing of a Memorandum of Understanding (MoU) to collaborate in...
Merck has announced the start of commercial production of its first GMP (Good Manufacturing Practices) compliant manufac...
Japan-based pharmaceutical firm Eisai Co. has agreed to end its global strategic collaboration with Bristol Myers Squibb...
US-based Emergent BioSolutions Inc. has entered into a definitive agreement to sell its drug product facility in Baltimo...
Asahi Kasei Medical's US subsidiary Bionova Scientific, a full-service biologics CDMO, has decided to launch a new busin...
CPHI North America reports soaring attendance and palpable excitement on the show floor, as investment returns and biolo...
WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies ...
IDT Australia has been awarded a Victoria State Government grant to part fund the establishment of Australia&rsq...
The life sciences industry is at a critical juncture in its digital transformation. Technological advancements including...
Ascend Advanced Therapies (Ascend), a total solutions gene therapy development partner, has acquired the CMC ...
Wood, a global leader in consulting and engineering, has been selected by leading biopharmaceutical firm Celltrion to ...
Danish pharma firm Novo Nordisk has announced that it would invest approximately 4 billion yuan (¥) in Tianjin for a...
China's WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO), has brok...
